Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGFac
1996

Targeted Inhibition of Tumor Cell Growth by a Bispecific Toxin

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): M Schmidt, W Wels

Primary Institution: Institute for Experimental Cancer Research, Tumour Biology Center, University of Freiburg, Germany

Hypothesis

Can a bispecific recombinant toxin effectively target and inhibit tumor cell growth by binding to both ErbB-2 and EGFR?

Conclusion

The bispecific toxin scFv(FRP5)-TGFa-ETA effectively inhibits tumor growth in vitro and in vivo by targeting both ErbB-2 and EGFR.

Supporting Evidence

  • The bispecific toxin was cytotoxic in vitro for tumor cells expressing various levels of the target receptors.
  • In vivo, scFv(FRP5)-TGFa-ETA potently inhibited the growth of established A431 tumor xenografts in nude mice.
  • Both scFv(FRP5)-TGFa-ETA and TGFa-ETA showed similar anti-tumor activity in vivo.

Takeaway

Scientists created a special protein that can stick to two different cancer cell parts to help kill the cancer cells better.

Methodology

The study involved constructing a bispecific recombinant toxin and testing its binding and cytotoxic effects on various human tumor cell lines and in a mouse model.

Limitations

The study does not address potential systemic toxicity in normal tissues expressing EGFR.

Participant Demographics

The study involved human tumor cell lines and athymic nude mice.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication